| EC | Endometrial Cancer |
| AUB | Abnormal Uterine Bleeding |
| TH/BSO | Total hysterectomy with bilateral salpingo-oophorectomy |
| TCGA | The Cancer Genome Atlas |
| ProMisE | Proactive Molecular Risk Classifier for endometrial cancer |
| LVSI | Lymphovascular space invasion |
| D&C | dilation and curettage |
| MRI | Magnetic Resonance Imaging |
| TVUS | Transvaginal ultrasound |
| LNG-IUD | Norgestrel-Releasing Intrauterine Device |
| ECOG | Eastern Cooperative Oncology Group |
| CR | Complete response rate |
| RR | Recurrence rate |
| PR | Pregnancy rate |
| LBR | Live birth rate |
| ART | Assisted Reproductive Technology |
| MSI | microsatellite instability |
| CN-L | copy-number low |
| CN-H | copy-number high |
| POLE-mut | POLE-mutated |
| MMRd | mismatch repair deficient |
| p53-abn | p53 Abnormality |
| NSMP | non-specific molecular profile |
| IHC | immunohistochemistry |
| POLE | polymerase epsilon |
| EDM | exonuclease domains |
| FIGO | International Federation of Gynecology and Obstetrics |
| EEC | endometrioid carcinoma |
| MSI-high | Microsatellite instability-High |
| MMR | Mismatch repair |
| ESMO | European Society for Medical Oncology |
| PCR-based | molecular Polymerase Chain Reaction-based |
| ER | Estrogen Receptor |
| PR | Progesterone Receptor |
| PORTEC | Post Operative Radiation Therapy in Endometrial Carcinoma |
| NGS | Next-Generation Sequencing |
| LNG-IUS | Levonorgestrel-releasing Intrauterine System |
| ESGO | European Society of Gynaecological Oncology |
| ESTRO | European Society for Radiotherapy and Oncology |
| ESP | European Society of Pathology |
| NCCN | National Comprehensive Cancer Network |
| RCT | Randomized Controlled Trial |
| AI | Artificial Intelligence |